Coegin Pharma AB (NGM:COEGIN)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.110
+0.100 (3.32%)
At close: Jul 22, 2025
3.32%
Market Cap77.37M
Revenue (ttm)n/a
Net Income (ttm)-22.83M
Shares Out24.88M
EPS (ttm)-1.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,129
Average Volume24,915
Openn/a
Previous Close3.010
Day's Rangen/a
52-Week Range3.010 - 7.260
Beta0.93
RSI39.48
Earnings DateJul 29, 2025

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol COEGIN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.